The NADPH-dependent respiratory burst oxidase of human neutrophils catalyzes the reduction of oxygen to superoxide using NADPH as the electron donor and is essential for normal host defenses. To gain insight into the function of the various oxidase subunits that are required for the full expression of catalytic activity, we studied the interactions between the 2 Ј ,3 Ј -dialdehyde derivative of NADPH (NADPH dialdehyde) and neutrophil cytosol. NADPH dialdehyde treatment of cytosol resulted in the loss of the ability of the cytosol to participate in cell-free oxidase activation; this inactivation was blocked by NADPH but not by NAD, NADP, or GTP. Partial purification of neutrophil cytosol yielded a single peak which could restore the activity lost in cytosol treated with NADPH dialdehyde. This peak contained p67
Introduction
An essential feature of normal host defense is the ability of phagocytic cells to deploy a group of highly reactive oxygen intermediates as microbicidal agents (1, 2) . The initial step in the production of these reactive oxidants is the one-electron reduction of oxygen to superoxide utilizing NADPH as the electron donor, a reaction catalyzed by a unique multicomponent enzyme system known as the leukocyte NADPH oxidase or respiratory burst oxidase (2) (3) (4) (5) . Inherited defects in any of the components of the oxidase result in chronic granulomatous disease (CGD), 1 a disorder characterized by frequent life-threatening infections and early mortality (6) (7) (8) . Examination of individuals afflicted by CGD has allowed identification of the essential components of the oxidase. These components include the two membrane-bound polypeptides p22 phox and gp91 phox (9) (10) (11) , which together make up cytochrome b 558 , and the two cytosolic polypeptides p47
phox and p67 phox (12) (13) (14) (15) , which exist largely in the form of a complex (16, 17) . The components are distributed in separate compartments in the unstimulated cell, but exposure of the cell to any of a wide variety of particulate or soluble agonists induces the association of the cytosolic components with the membrane-associated components to assemble the active oxidase (16, 18, 19) . This process has been reproduced in vitro using cell-free systems in which oxidase assembly can be induced by the addition of an amphopathic agent to reaction mixtures containing all of the oxidase components (20-23). Experiments using these cell-free oxidase-activating systems have shown that in addition to the components named above, the guanine nucleotide-binding protein Rac2 is also required for oxidase activation (24) (25) (26) (27) (28) .
Despite agreement that these oxidase components are required for enzyme activity, aspects of the function of these components are unclear. During oxidase activation in intact cells, p47
phox is extensively phosphorylated (29) (30) (31) (32) , an event thought to participate in the initiation of enzyme assembly in vivo. The function of p67 phox is less well understood, although data suggest that it may interact with Rac2 (33) . The membrane associated cytochrome b 558 , which contains both FAD and heme, is generally thought to be the terminal electron carrier of the oxidase (34, 35) . This cytochrome has also been postulated to contain the catalytic NADPH-binding site of the oxidase, based on sequence homologies and some affinity-labeling experiments (34) (35) (36) . Earlier studies using the 2 Ј ,3 Ј -dialdehyde analog of NADPH (NADPH dialdehyde), however, suggested that a catalytically significant NADPH-binding component was present in the cytosol. NADPH dialdehyde was found to be a substrate for the oxidase, but treatment with the dialdehyde resulted over time in the irreversible loss of the ability of the cytosol to participate in cell-free oxidase systems (37-39). Examination of this interaction showed that only one oxidase component was affected by the dialdehyde. Furthermore, the K m for NADPH dialdehyde as an oxidase inactivator was the same as its K m as substrate, while NADPH protected the oxidase against inactivation by the dialdehyde with a K i that was the same as its (i.e., NADPH's) K m as substrate (38). On the other hand, the ability of neutrophil membranes (containing cytochrome b 558 ) to support oxidase activity in the cell-free system was completely unaffected by treatment with NADPH dialdehyde (37, 39). Therefore, any NADPH binding site present on cytochrome b 558 had to be inaccessible to the dialdehyde, at least before oxidase assembly.
To understand the significance of these observations with NADPH dialdehyde, we undertook to identify the cytosolic oxidase component that contained the dialdehyde-sensitive NADPH-binding site. We now present evidence that the dialdehyde-sensitive NADPH-binding site is on p67 phox , and that this NADPH binding site is essential for oxidase activity.
Methods
Materials. All reagents were obtained from the Sigma Chemical Co. (St. Louis, MO) unless noted otherwise.
Preparation of neutrophil fractions. Neutrophil membrane and cytosol for cell-free assay of the leukocyte NADPH oxidase were prepared from cells harvested by leukapheresis from normal donors as described previously (38). Cell fractions were stored at Ϫ 70 Њ C until use.
Synthesis of 2 Ј ,3 Ј NADPH dialdehyde and treatment of neutrophil cytosol. NADPH dialdehyde was prepared by periodate oxidation of NADP followed by reduction to NADPH dialdehyde using isocitric dehydrogenase (37). [ 32 P]NADPH dialdehyde was synthesized as previously described (40). Neutrophil cytosol in which the dialdehyde-sensitive oxidase component has been inactivated with NADPH dialdehyde was prepared and used as previously described (38). Briefly, neutrophil cytosol was incubated with 0.1 mM NADPH dialdehyde in the presence of 0.5 mM NaCNBH 3 for 18 h at 4 Њ C. After the incubation, the inactivated cytosol was dialyzed against cell-fractionation buffer to remove unbound NADPH dialdehyde and NaCNBH 3 , and then stored in aliquots at Ϫ 70 Њ C for use in assays of complementing activity. As we have previously shown (37, 38), the resulting product has a markedly reduced ability to participate in a cell-free oxidase activation assay ( Ͼ 95% loss of activity compared to untreated cytosol).
For examination of the sensitivity of cytosol or recombinant p67 phox to treatment with NADPH dialdehyde, the incubation time was reduced to 6 h and various nucleotides were added (1.0 mM final concentration) to test their ability to block the inactivation process (38).
Assay of NADPH oxidase activity. For cell-free assay of the oxidase, solubilized neutrophil membranes and cytosol, 6 ϫ 10 5 and 2 ϫ 10 6 cell equivalents, respectively, are usually combined in the well of a 96-well plate in the presence of 0.1 mM ferricytochrome c and 0.16 mM NADPH (38). Activation is achieved by the addition of SDS (0.04 mM final concentration) and the formation of ferrocytochrome is followed at 550 nm. Results are expressed as nanomoles ferricytochrome reduced per min per 10 7 cell equivalents of membrane in the well containing the reaction mixture minus the rate of reduction in a well containing the identical components plus 0.045 mg of superoxide dismutase. For assay of activity complementing that missing in NADPH dialdehyde-treated cytosol (complementing activity), 2 ϫ 10 6 cell equivalents of dialdehyde-treated cytosol was added in place of normal cytosol. Fractions to be assayed for activity (0.05 ml) were then added and the reaction initiated with the addition of SDS. Because the dialdehyde-treated cytosol possesses minimal activity on its own, background activity was not subtracted from the assay results. For calculation of recovery, 1 U of complementing activity was defined by the ability to increase superoxide production in this assay system by 1 nmol/min per 10 7 cell equivalents of membrane. For assay of activity contributed by various cytosolic oxidase components, a cell-free reaction mixture was used as described above, but with only sufficient normal neutrophil cytosol (0.04-0.08 ϫ 10 6 cell equivalents) to supply a threshold amount of each cytosolic oxidase component. The addition of preparative fractions containing one or more of any of the cytosolic oxidase components will then lead to increased oxidase activity after activation (41) . The exact quantity of added cytosol was established by titration before each set of assays, and the amount of cytosol that contributed Ϸ 1-3 nmol/min per 10 7 cell equivalents of membrane of oxidase activity was used in the subsequent assays. This background signal was subtracted for calculation of activity present in chromatographic fractions; the mean background for all assays was 2.4 Ϯ 0.4 nmol/min per 10 7 cell equivalent membrane. Partial purification of the NADPH dialdehyde-sensitive cytosolic component of the NADPH oxidase. Chromatographic purification was conducted at 4 Њ C. To 25 ml neutrophil cytosol, sufficient ammonium sulfate was added with gentle stirring to bring the solution to 40% saturation. Complementing activity (see above), assayed with NADPH dialdehyde-treated cytosol, was found in the precipitate, which was isolated by centrifugation (12,000 g , 30 min at 4 Њ C), dissolved in 10 ml buffer (0.1 M Tris pH 8.0, 10% ethylene glycol, 0.5 mM PMSF, 0.002 mM leupeptin, 1 mM EGTA, and 3.5 mM MgCl 2 ) and dialyzed overnight against the same buffer (but with 0.02 M Tris) before assay. The dialyzed solution containing the complementing activity was applied to a 5 ϫ 0.5 cm Mono-Q column that had been Figure 1 . Partial purification of the NADPH dialdehyde-sensitive cytosolic component of the leukocyte NADPH oxidase. Neutrophil cytosol was subjected to ammonium sulfate precipitation followed by chromatography over Mono Q and superose columns as described in the text. Sequential chromatographic profiles from a typical separation are shown in A. The absorbance at 280 nm is shown by the solid line. Column fractions were examined for their ability to restore activity to cell-free oxidase activation assays containing NADPH dialdehyde-treated cytosol (open circles) or subthreshold amounts of normal cytosol (closed circles). Fractions were also examined for the presence of cytosolic oxidase components by immunoblotting. Immunoblots for p47 phox and p67 phox are shown below the chromatographic profiles. p67
phox coelutes with activity in both assay systems, while p47 phox was only found in the passthrough fractions of the Mono Q column, and Rac2 was not detectable (not shown). equilibrated with dialysis buffer, and then eluted at 0.5 ml/min by FPLC using a KCl gradient as shown in Fig. 1 . Half milliter fractions were collected and 0.05-ml portions of each fraction were assayed for activity. The active fractions were pooled, concentrated to 0.25 ml in a Centricon 3 concentrator (Amicon Corp., Beverly MA) and applied to a 10 ϫ 30 cm Superose 12 column equilibrated with modified relaxation buffer (0.05 M Pipes pH 7.4, 3.5 mM MgCl 2 , 0.5 mM PMSF, 1 mM EGTA, 0.002 mM leupeptin, and 10% ethylene glycol). The column was eluted with the same buffer, running the column at 0.25 ml/ min, collecting 0.5-ml fractions and assaying for complementing activity as above. For immunoblotting, 0.05 ml of each fraction was subjected to SDS-PAGE over a 12% polyacrylamide gel (42). The separated proteins were transferred to a polyvinylidene difluoride membrane (43) , and p47 phox and p67 phox were detected with a 1:5,000 dilution of a mixture of rabbit polyclonal antibodies raised against 11 amino acid peptides corresponding to the carboxy termini of p47 phox and p67 phox , respectively (44) , visualizing bound antibody with goat anti-rabbit IgG conjugated to alkaline phosphatase and developing with 5-bromo-chloro-3-indolyl phosphate/nitro blue tetrazolium (Western Blue; ProMega Corp., Madison, WI). Rac2 was detected in a similar fashion using a 1:500 dilution of polyclonal anti-Rac2 antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA).
Preparation of recombinant p67 phox . A recombinant baculovirus expressing p67
phox was the generous gift of Dr. T.L. Leto. A spinner flask containing 2 ϫ 10 8 SF9 insect cells was infected with the recombinant baculovirus (45) ; another flask of cells were infected with Ac-MNPV virus without an insert (Invitrogen Corp., San Diego, CA). The cells were incubated for 40 h before they were isolated by centrifugation (400 g , 10 min), washed, treated with diisopropylfluorophosphate, and subjected to nitrogen cavitation as previously described for preparation of neutrophil fractions (38). Nuclei and unbroken cells were removed by centrifugation (2,000 g , 10 min) and the low speed supernatant was subjected to further centrifugation (100,000 g , 60 min). The high-speed supernatant of the cells was subjected to Mono-Q chromatography as described for neutrophil cytosol above, but using a gradient of NaCl as shown in Fig. 2 . Complementing activity in the Mono-Q fractions was assayed as described above, and the content and purity of p67 phox in the fractions were evaluated by immunoblotting and Coomassie blue staining, respectively.
Labeling of recombinant p67 phox by [
phox (10 g, from the fraction eluting at 19 ml in the chromatogram shown in Fig. 2 ) was incubated for various times with 0.03 mM ( ‫ف‬ 0.5-1.0 Ci) [ 32 P]NADPH dialdehyde in the absence and presence of 0.3 mM unlabeled NADPH dialdehyde or 5 mM NADPH in 0.1 ml buffer-containing triethanolamine HCl (0.05 M, pH 8.0) and lysine HCl (10 mM). Reaction mixtures were analyzed by SDS-PAGE followed by autoradiography. Quantitative labeling was accomplished as previously described (46) . Briefly, aliquots of p67 phox were treated as above, and the reactions were allowed to proceed for 18 h to ensure maximum incorporation of NADPH dialdehyde. At the conclusion of the incubation, samples were exhaustively dialyzed ( n ϭ 2) or subjected to SDS-PAGE followed by hydrolysis in H 2 O 2 of the band at 67 kD, and the incorporated radioactivity determined by scintillation counting.
Results
We isolated the NADPH-binding component from the cytosol using a modified cell-free oxidase activating system in which normal cytosol was replaced with cytosol that had been extensively inactivated ( Ͼ 95%) by treatment with NADPH dialdehyde. The dialdehyde-mediated inactivation of neutrophil cytosol could be blocked by NADPH, as we had previously found (37), but not by NAD, NADP, or GTP (Table I) . Fractions containing the dialdehyde-sensitive component were identified by their complementing activity, defined as their ability to restore oxidase activity to a system containing cytosol that had been treated with NADPH dialdehyde. Purification of normal neutrophil cytosol by ammonium sulfate fractionation followed by Mono-Q anion exchange chromatography and then gel filtration over a Superose column was carried out four times and consistently yielded a single major peak of complementing activity from each column (Fig. 1) . Immunoblotting showed that the active fractions from both the Mono Q and Superose columns contained p67 phox (Fig. 1 ), but not p47 phox or Rac2 (not shown). Activity could also be detected in the pass-through fractions from the Mono-Q column when the assay was carried out with limiting quantities of normal cytosol rather than with dialdehyde-treated cytosol; these active fractions contained p47 phox . The fractions from the Superose column, however, showed only the single peak of activity that had been detected with dialdehyde-treated cytosol when the assays were repeated with normal cytosol. The protein content of this phox to restore oxidase activity to a cell-free oxidase-activating system containing NADPH dialdehydetreated cytosol. A spinner flask containing 2 ϫ 10 8 SF9 cells was infected with a recombinant baculovirus expressing p67 phox (left), or with the AcMNPV vector without an insert (right), and then incubated at 28ЊC for 40 h. The cytosol fraction of the cells was prepared as described in Methods and then run over a Mono-Q column eluting with a gradient of NaCl (dotted line). Complementing activity in the Mono-Q fractions was assayed as described (open and closed circles) and the content and purity of p67 phox in the fractions was evaluated by immunoblotting and Coomassie blue staining. p67 phox was present in fractions eluting between 18 and 20.5 ml. The fractions containing antigenic p67 phox were coincident with those containing activity complementing NADPH dialdehyde-treated cytosol. A single polypeptide migrating at 67 kD was identified in this peak when aliquots of each fraction (15 l) were subjected to SDS-PAGE and Coomassie staining. The fraction eluting at 19.0 ml was used in the labeling experiments shown in Fig. 3 where the Coomassie-stained gel is shown. Fractions obtained by the same purification procedure from cells infected with the wild-type virus contained no material crossreacting with anti-p67 phox and did not contain activity in the complementation assays using NADPH dialdehyde-inhibited cytosol or using a subthreshold amount of normal cytosol.
peak was ‫ف‬ 23 g or 0.04% of the protein present in the initial aliquot of cytosol. There was a 25-fold enrichment of complementing activity (Table II) , although the recovery was only ‫ف‬ 1%. The greatest loss of activity occurred with the initial ammonium sulfate precipitation step, but significant additional losses of activity occurred over time and with each isolation step. Instability of the oxidase and its component parts during purification attempts has been noted previously and is enhanced when any individual component is separated from the original complex of cytosolic components (41, 47, 48) . SDS-PAGE of the final Superose peak showed at least six polypeptides, one of which migrated an apparent molecular weight of 67 kD and was identified as p67 phox by immunoblotting. Thus of the three cytosolic components required for the cell-free oxidase system (i.e., p47 phox , p67 phox , and Rac2) only p67 phox was found to be present in the fractions containing complementing activity. These findings suggested p67 phox may be the NADPH dialdehyde-sensitive cytosolic component of the leukocyte NADPH oxidase.
To confirm that p67 phox contained an essential NADPHbinding site and was responsible for reconstituting the activity in our assay system, we carried out experiments to determine whether recombinant p67 phox expressed in a baculovirus system and purified to homogeneity demonstrated complementing activity. The results showed that purified recombinant p67 phox restored activity to cytosol treated with NADPH dialdehyde ( Fig. 2 and Table II) , while a similar preparation from SF9 cells infected with wild-type baculovirus had no effect. The complementing activity of the recombinant p67 phox was abolished by treatment with NADPH, though not by NAD, NADP, or GTP (Table I) . That the loss of p67 phox -complementing activity by treatment with NADPH dialdehyde was Activity complementing that lost in NADPH dialdehyde-treated cytosol was isolated as described in the text. The yields of activity from the ammonium sulfate precipitation and the successive chromatography stages displayed in Fig. 1 are shown. 1 U of complementing activity was defined as that able to increase superoxide production by 1 nmol/min per 10 7 cell equivalents of membrane in a cell-free oxidase assay performed in the presence of NADPH dialdehyde treated cytosol as described in Methods. There was a 25-fold enrichment in activity contained in neutrophil cytosol over the three steps, although there was substantial loss of total activity at each step. Chromatography of extracts of SF-9 cell infected with recombinant baculovirus expressing p67 phox over the Mono-Q column yielded a peak of activity that was comparable to that of the purified neutrophil cytosol fraction. not associated with apparent fragmentation of the molecule was shown by examination of reaction mixtures by SDS-PAGE and subsequent Coomassie staining (Fig. 3) or immunoblotting (data not shown).
Affinity labeling studies showed that p67 phox was labeled by [ 32 P]NADPH dialdehyde (Fig. 3) . Labeling by the 32 P-tagged dialdehyde was decreased significantly by unlabeled NADPH dialdehyde and by NADPH. Excesses of NAD, NADP, or GTP had no effect on the labeling of the protein (not shown). When [ 32 P]NADPH dialdehyde labeling was carried out overnight, quantitation of bound radioactivity showed that 0.83Ϯ0.11 mol of NADPH dialdehyde were bound per mol of p67 phox (n ϭ 4 using two different p67 phox preparations). Binding of [ (Fig. 3,  right) suggested that specific incorporation of radioactivity parallelled the time course of inactivation of cytosol by NADPH dialdehyde we have previously reported (37). Incorporation of label into p67 phox at 6 h (subtracting background labeling in the presence of an excess of cold NADPH dialdehyde) was ‫ف‬ 70% of the maximum value, a value similar to the extent of inactivation of recombinant p67
phox by NADPH dialdehyde shown in Table I .
Discussion
Some time ago, we extended a study of Minakami's (49) by examining the effect of the 2Ј,3Ј-dialdehyde analog of NADPH on the activity of a cell-free -forming system from resting neutrophils. We found that NADPH dialdehyde was a substrate for the oxidase, but that over time the dialdehyde destroyed the ability of resting cytosol to support production in the cell-free system (37). Kinetic studies showed that the K m for NADPH dialdehyde as an oxidase inactivator was the same as its K m as substrate, while native NADPH protected the cytosol against inactivation by the dialdehyde with a K i that was the same as its (i.e., NADPH's) K m as substrate. These results indicated that NADPH dialdehyde inactivated the oxidase by behaving as an affinity label, forming a Michaelis complex at the NADPH binding site of a cytosolic compo-
nent of the oxidase, and over time attaching itself there irreversibly to destroy catalytic activity of the enzyme: phox itself (34) (35) (36) (49) (50) (51) . Most of these identifications were based on sequence homologies and affinity-labeling experiments, although there is good enzymological evidence for a catalytically functional NADPH binding site on gp91
phox (see below). In the present study, the identification of p67 phox as an NADPH binding oxidase subunit was suggested by sequence homologies between p67 phox and the postulated pyridine nucleotide-binding sites of a number of NADP(H)-dependent enzymes (Table III) . However, the inability of other investigators to define consensus canonical cofactor binding sequences for NADP(H) dependent enzymes (52) suggest that sequency homologies are likely to provide only weak evidence about the role of p67 phox as an NADPH-binding protein, and that conclusions regarding NADPH binding by p67 phox have to be based on other approaches. Final identification of p67 phox as an NADPHbinding protein was accomplished by affinity labeling of p67 phox with radioactive NADPH dialdehyde and by examining the activity of NADPH dialdehyde-treated and untreated p67 phox in the cell-free oxidase activating system. The latter measurements established the significance of the NADPH binding capacity of p67 phox for the catalytic activity of the oxidase. In an earlier study, we found a ‫ف‬ 30-kD polypeptide that was translocated from cytosol to membranes of activated neutrophils and could be labeled with [ phox was first postulated on the basis of sequence homologies, and it was later shown that purified cytochrome b 558 , if mixed with FAD and lipids of appropriate composition, can catalyze production in the absence of any cytosolic factors, implying the presence of a catalytically significant NADPH-binding site (54, 55) . The turnover number for production in a system free of cytosol, however, was only 15-20% of the turnover number for cell-free systems containing cytosolic factors, and the K m for NADPH was ‫ف‬ 0.125 mM, a value that is fourfold higher than the K m of ‫ف‬ 0.035 mM that is routinely obtained with the complete cell-free system. These values indicate that with the oxidase working under V/K conditions, as most enzymes do, the rate of production using the gp91 phox NADPH-binding site alone would be at most 6% of the rate seen with the complete oxidase, and this rate would prevail only if the cytochrome were in an ideal lipid environment. Some means of accelerating the forming reaction would seem to be necessary. Our results suggest a possible mechanism. We propose that the leukocyte NADPH oxidase contains two catalytically functional NADPH-binding sites, one of relatively low affinity on gp91 phox and the other of higher affinity on p67 phox , and that the kinetic properties of the oxidase reflect the balance between the two. When p67 phox is brought to the electron transport apparatus during oxidase activation, these two domains may cooperate to form the single catalytically efficient NADPH-binding site found on the active enzyme. Available evidence suggests that the active oxidase contains equimolar quantities of p47 phox , p67 phox , and cytochrome b 558 , findings consistent with a role for p67 phox in enzyme catalysis (56, 57) . Support for this interpretation of electron transport through the oxidase is provided by a number of disparate observations. For instance, there are certain CGD patients with partial defects in production, in whom the oxidase shows a K m for NADPH of 0.125 mM or higher (58) . A high K m has also been demonstrated in cell-free oxidase activation systems at very low cytosol concentrations (59, 60) , and can be corrected by the addition of cytosol-containing p67 phox (59) but not by cytosol treated with NADPH dialdehyde (38). Finally, the activation of mononuclear phagocytes is associated with a reduction in the K m of the oxidase for NADPH from values of ‫ف‬ 0.15 mM or greater to levels similar to those measured in neutrophils, i.e., ‫ف‬ 0.035 mM (61) (62) (63) (64) . It is possible that this low affinity state of the oxidase may arise through inadequate quantities of p67 phox or through faulty interactions between p67 phox and cytochrome b 558 such that the substrate associates
directly with the NADPH binding site on gp91 phox rather than that on p67 phox . Why might this complicated system involving NADPHbinding sites functioning sequentially or in parallel have evolved? The leukocyte NADPH oxidase is a very dangerous enzyme, responsible for the generation of highly reactive oxidizing agents that have the potential for inflicting great harm. The activity of the oxidase must therefore be stringently controlled as to time and location and the leakage of electrons to oxygen through the resting enzyme must be kept to an irreducible minimum. Distributing the active site of the oxidase between two components that are only brought together when the enzyme is activated represents a unique solution to this problem.
